1. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. (November 2022) Authors: Alexander, James L; Liu, Zhigang; Muñoz Sandoval, Diana; Reynolds, Catherine; Ibraheim, Hajir; Anandabaskaran, Sulak; Saifuddin, Aamir; Castro Seoane, Rocio; Anand, Nikhil; Nice, Rachel; Bewshea, Claire; D'Mello, Andrea; Constable, Laura; Jones, Gareth R; Balarajah, Sharmili; Fiorentino, Francesc... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 11(2022) Page Start: 1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. (April 2022) Authors: Alexander, James L; Kennedy, Nicholas A; Ibraheim, Hajir; Anandabaskaran, Sulak; Saifuddin, Aamir; Castro Seoane, Rocio; Liu, Zhigang; Nice, Rachel; Bewshea, Claire; D'Mello, Andrea; Constable, Laura; Jones, Gareth R; Balarajah, Sharmili; Fiorentino, Francesca; Sebastian, Shaji; Irving, Peter M; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 4(2022) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial. Issue 10 (October 2021) Authors: Al-Shahi Salman, Rustam; Keerie, Catriona; Stephen, Jacqueline; Lewis, Steff; Norrie, John; Dennis, Martin S.; Newby, David E.; Wardlaw, Joanna M.; Lip, Gregory Y.H.; Parry-Jones, Adrian; White, Philip M.; Baigent, Colin; Lasserson, Dan; Oliver, Colin; O'Mahony, Fiach; Amoils, Shannon; Bamford, J... Journal: Lancet neurology Issue: Volume 20:Issue 10(2021) Page Start: 842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗